Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320905 · ClinicalTrials.gov registry record
Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation
A clinical trial, sponsored by Summa Health System.
- Completed
- Registry status
- 70
- Enrollment target
NCT00320905: Completed study, sponsored by Summa Health System.
NCT00320905 is a clinical trial that has completed, run by Summa Health System. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320905 has completed, sponsored by Summa Health System.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The proposed study will be the first to examine whether changes in blood flow patterns within the brain account for the possible cognitive benefits of CR. A clearer understanding of this possibility may provide key insight into the way CVD affects the brain, help identify effective treatments, help a greater number of patients return to work, and improve quality of life.
Interventions
- BEHAVIORAL Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-03 |
What the finished NCT00320905 record still lists
NCT00320905 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT00320905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00320905 about?
NCT00320905 is a clinical study titled "Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation". The proposed study will be the first to examine whether changes in blood flow patterns within the brain account for the possible cognitive benefits of CR. A clearer understanding of this possibility may provide key insight into the way CVD affects the brain, help identify effective treatments, help ...
What is the current status of trial NCT00320905?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2006-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00320905?
The interventions under investigation include: Observational (BEHAVIORAL).
Who is sponsoring clinical trial NCT00320905?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia